According to data provided by Zacks Research, Seattle Genetics, Inc. (NASDAQ:SGEN) has a consensus target price of $61 on the stock. Out of the polled analysts providing targets, the high is currently $75, while the low is resting at $43. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting Seattle Genetics, Inc. (NASDAQ:SGEN) to post a current quarter EPS of $-0.44. This consensus number is compiled by Zacks Research. For the period ending on 2017-03-31, the company reported EPS for the quarter of $-0.42. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was -2.44%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-07-25.
In terms of analyst ratings, Seattle Genetics, Inc. (NASDAQ:SGEN) has a current ABR of 2.42. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.
During the most recent trading session, Target Corporation (NYSE:TGT) shares traded +0.00%. Tracking the stock price in relation to moving averages may provide enhanced perspective on stock performance. After a recent look, the stock has been seen trading $-1.09 off of the 50-day moving average of $55.22 and $-9.80 separated from the 200-day moving average of $63.93. Taking a further look from a different perspective, the stock has been recently recorded -31.77% off of the 52-week high of 79.33 and +2.67% apart from the 52-week low of 52.72. Monitoring stock price activity relative to moving averages and the highs and lows for the past year might help with future stock price value assessment.
Price Target in Focus
While monitoring stock technicals is important, most investors are more concerned with where the stock might be going now. Equity research analysts have provided views on where they believe the stock will be trading in the future. According to Thomson Reuters, sell-side analysts are projecting a consensus target price of $59.11 on company shares. This is a near-term estimate for the next 12-18 months.
Currently, Target Corporation Common Stock has a price to earnings ratio of 11.09. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The stock currently has a PEG Ratio of -1.88.